Hikma Pharmaceuticals PLC | Ownership
Companies that own Hikma Pharmaceuticals PLC
Capital Research & Management Co. (World Investors)
15,380,940
6.37%
-470,226
0.06%
08/24/2018
Capital Research & Management Co. (Global Investors)
11,256,415
4.66%
595,837
0.05%
08/24/2018
FIL Investment Advisors (UK) Ltd.
9,791,950
4.05%
7,767,950
0.26%
03/13/2018
Capital International Ltd.
3,044,380
1.26%
0
0.95%
06/30/2018
Genesis Investment Management LLP
2,698,571
1.12%
-322,700
0.34%
08/02/2018
The Vanguard Group, Inc.
2,646,000
1.1%
339,000
0%
08/02/2018
Legal & General Investment Management Ltd.
2,325,000
0.96%
18,000
0.03%
08/02/2018
Templeton Investment Counsel LLC
1,829,615
0.76%
490,873
0.22%
08/02/2018
BlackRock Fund Advisors
1,321,498
0.55%
748
0%
09/06/2018
RBC Global Asset Management (UK) Ltd.
1,285,844
0.53%
-152,032
0.17%
09/29/2017
| Address |
1 New Burlington Place
London Greater London W1S 2HR
United Kingdom
|
|
Employees
|
- |
| Website |
http://hikma.com |
| Updated |
07/08/2019 |
| Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment offers selling of branded generics and in-licensed patented products. |
